Insiders who reported open-market trades in the last 12 months at the companies Michael Egholm files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Michael Egholm is a corporate insider, tracked as President & CEO, Director of STANDARD BIOTOOLS INC. (LAB). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael Egholm submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Michael Egholm been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($15K) across all tracked filings.
Michael Egholm is President & CEO, Director of STANDARD BIOTOOLS INC. (LAB). 14 SEC Form 4 filings on record going back to 2024, most recently on 24 August 2026. Most recent open-market trade: sold $5K of LAB on 23 May 2025. Lifetime open-market sales: $15K.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Michael Egholm.
InsiderAlpha's records for Michael Egholm go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
